Phase II study of the combination of Bevacizumab (rhuMab VEGF) plus Capecitabine with pre-operative standard radiotherapy in patients with locally advanced rectal cancer.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2008
This article has no abstract
Epistemonikos ID: 641a2491387c2545abe2feccc5bbaacd027ab29c
First added on: Jan 21, 2025